Resistance Training Beneficial in PsA Regardless of Format Resistance Training Beneficial in PsA Regardless of Format
Two types of strength training were associated with similar improvements in function and disease activity in a randomized trial of patients with psoriatic arthritis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 10, 2024 Category: Consumer Health News Tags: Rheumatology Source Type: news

Using Baseline Markers to Predict Response in Psoriatic Arthritis
(MedPage Today) -- In this final of four exclusive episodes, MedPage Today brought together three expert leaders in the field, all from the Cleveland Clinic -- moderator M. Elaine Husni, MD, MPH, is joined by Leonard Calabrese, DO, and Anthony... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 13, 2023 Category: Dermatology Source Type: news

Improvements With Guselkumab in Psoriatic Arthritis Seen Across All MDA Domains
(MedPage Today) -- At the American College of Rheumatology annual meeting, results from the phase IIIb COSMOS trial were presented that examined the association between patient- and physician-reported domains and minimal disease activity (MDA... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - December 6, 2023 Category: Rheumatology Source Type: news

Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis
(MedPage Today) -- Patients with plaque psoriasis who screened positive for psoriatic arthritis in the POETYK PSO-1 and POETYK PSO-2 trials reported greater improvements in joint activity and joint pain scores when treated with deucravacitinib... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 6, 2023 Category: Dermatology Source Type: news

Key Data on Psoriatic Arthritis From ACR 2023 Key Data on Psoriatic Arthritis From ACR 2023
Key data on psoriatic arthritis from ACR 2023 include treatment studies examining izokibep, apremilast, and TAK-279, as well as analysis of treatment response and difficult-to-treat cases.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 6, 2023 Category: Consumer Health News Tags: Rheumatology ReCAP Source Type: news

Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis
(MedPage Today) -- Patients with plaque psoriasis who screened positive for psoriatic arthritis in the POETYK PSO-1 and POETYK PSO-2 trials reported greater improvements in joint activity and joint pain scores when treated with deucravacitinib... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 5, 2023 Category: Dermatology Source Type: news

PsA Raises Mortality Risk, but Unevenly
(MedPage Today) -- Swedes with psoriatic arthritis (PsA) tended to die earlier than other people, a national case-control study indicated, but the risk varied considerably among different subgroups. Overall all-cause mortality was 11% higher for... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - December 4, 2023 Category: Dermatology Source Type: news

New Data on Bimekizumab in Psoriatic Arthritis
(MedPage Today) -- At the American College of Rheumatology annual meeting, new data was presented on the long-term safety and efficacy of bimekizumab (Bimzelx), a dual interleukin (IL)-17A/F inhibitor, in active psoriatic arthritis. In this second... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 30, 2023 Category: Dermatology Source Type: news

Picture quiz: Toenail presentations
The Nursing in Practice ‘picture quizzes’ aim to test your knowledge through photo presentations of symptoms. Work your way through them to understand the key clinical problems faced by patients, and how to correctly identify them. Press ‘start’ below to begin the quiz.  A 45-year-old woman is concerned about this black line that has appeared under her big toenail. Can you reassure her about the cause? Fungal nail infection Melanoma Subungual haematoma Ingrowing toenail A 23-year-old woman wants to know what you are going to do about her ‘manky toenail’ as it is summer and she feels she ...
Source: Nursing in Practice - November 23, 2023 Category: Nursing Authors: Mollie Fraser-Andrews Tags: Dermatology Quiz toenail Source Type: news

New Data on TYK2 Inhibitors for Psoriasis, Psoriatic Arthritis
(MedPage Today) -- Studies were presented at the American College of Rheumatology (ACR) annual meeting on the safety and efficacy of two oral tyrosine kinase 2 (TYK2) inhibitors -- TAK-279, a selective TYK2 inhibitor in patients with active psoriatic... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 22, 2023 Category: Dermatology Source Type: news

IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA
Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - November 21, 2023 Category: Dermatology Tags: Rheumatology News Source Type: news

Novel IL-17A Blocker Continues to Impress in PsA
(MedPage Today) -- SAN DIEGO -- The triple-action investigational agent known as izokibep was highly effective against psoriatic arthritis (PsA) over 46 weeks in a new analysis of the product's first phase II trial, a researcher said here. Following... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - November 14, 2023 Category: Rheumatology Source Type: news

Aclaris halts work on its experimental rheumatoid arthritis drug after clinical trial failure
Aclaris will discontinue further development of the drug candidate, including halting enrollment of its ongoing phase 2 trial targeting psoriatic arthritis. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 14, 2023 Category: Pharmaceuticals Authors: John George Source Type: news

FDA Approves Abatacept for Pediatric Patients With Psoriatic Arthritis FDA Approves Abatacept for Pediatric Patients With Psoriatic Arthritis
As many as 5% of pediatric patients with juvenile idiopathic arthritis are estimated to have juvenile PsA.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 31, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

Phenotype-Targeted Treatment Sought for Psoriatic Disease Phenotype-Targeted Treatment Sought for Psoriatic Disease
Researchers described ongoing work to"understand the discrete and overlapping endotypes that underlie the phenotypes" of psoriatic disease and to develop a diagnostic test for psoriatic arthritis.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - October 26, 2023 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news